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2Experimental Section
1. General Methods
Starting materials and reagents were purchased from Aldrich or Fisher and 
used as received. Cyclobis(paraquat-p-phenylene) tetrakis(hexafluorophosphate)[S1] 
(CBPQT·4PF6) monotosylated tetraethylene glycol[S2] 1, and the alkyne-functionalized 
stopper precursor 5[S3] were prepared following procedures already reported in the 
literature. All reactions were performed under an argon atmosphere and in dry  solvents, 
unless otherwise stated. Analytical thin-layer chromatography  (TLC) was performed on 
aluminum sheets, precoated with silica gel 60-F254 (Merck 5554).  Flash chromatography 
was carried out using silica gel 60 (Silicycle) as the stationary phase. HPLC purification 
was performed on a preperative RP-HPLC instrument, using a C18 column (Agilent, 
10µm packing, 30 mm × 250 mm) . The eluents used were MeCN and H2O, both mixed 
with 0.1 % (v / v) trifluoroacetic acid (TFA). The detector was set to λ = 254 nm. 1H and 
13C NMR spectra were recorded on either a Bruker Avance 500 MHz, or a Bruker Avance 
600 MHz spectrometer at ambient temperature, unless otherwise noted. VT-NMR spectra 
were recorder on a Bruker Avance 600 MHz spectrometer and temperature-calibrated 
using neat  MeOH (for T < 295 K) and ethylene glycol (for T > 295 K). Chemical shifts 
are reported in ppm relative to the signals corresponding to the residual non-deuterated 
solvents (CDCl3: δ 7.26 ppm, CD3CN: δ 1.94 ppm, (CD3)2CO: δ 2.05). High resolution 
electrospray  ionization (HR ESI) mass spectra were measured on an Micromass Q-TOF 
Ultima mass spectrometer. Matrix assisted laser desorption and ionization – time of flight 
(MALDI-TOF) mass spectrometry were performed, using a Bruker Autoflex III 
instrument.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
32. Synthetic Procedures
2: 1,5-Dihydroxynaphthalene (8.0 g, 49.9 mmol) was placed in a clean and dry  round- 
bottomed flask with dry  MeCN under argon.  K2CO3 (17.13 g, 124.9 mmol) and 18-
crown-6 (100 mg, 0.5 mmol) were added to the solution and it was heated under reflux 
for 1 h before monotosylated tetraethylene glycol[S2] 1 (43.5 g, 124.9 mmol) was added. 
The reaction mixture was refluxed under argon for 24 h and the solvent was removed 
thereafter under reduced pressure, before the reaction mixture was washed with H2O and 
then extracted with small quantities, first of all with EtOAc and then with CH2Cl2. The 
organic layers were combined, dried (Na2SO4) and the solvent was removed under low 
pressure to yield the crude product, which was subjected to column chromatography 
[SiO2: MeOH / EtOAc (5:95)]. The diol 2 was obtained as a reddish yellow oil (18.8 g, 
86%). 1H NMR (500 MHz, CDCl3, 298 K): δ = 7.85 (d, J = 8.4 Hz, 2H), 7.34 (t, J = 7.8, 
2H), 6.83 (d, J = 7.7 Hz, 2H), 4.28 (t, J = 4.7, 4H), 3.98 (t, J = 4.9 Hz, 4H), 3.80−3.78 
(m, 4H), 3.70−3.63 (m, 18H), 3.57−3.55 (m, 4H) ppm. 13C NMR (125 MHz, CDCl3, 
298K): δ = 154.3, 126.6, 125.1, 114.5, 105.6, 70.6, 69.9, 67.8, 61.6 ppm. MALDI-TOF 
MS m/z calcd for 512.58; found 512.05 [M]+.
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Scheme S1. The synthesis of the tetraethyleneglycol substituted DNP 2 (1NP), 
namely, 1,5-bis[2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)ethoxy]naphthalene 
(BHEEEEN)
43: Et3N (290 mg, 0.42 mL, 2.92 mmol) and N, Nʹ′- dimethylaminopyridine (DMAP) (120 
mg, 0.97 mmol) were added to a solution of the diol 2 (500 mg, 0.975 mmol) in dry 
CH2Cl2 (50 mL) at 0 ˚C under a nitrogen atmosphere. After 5 min, a solution of p-
toluene- sulfonylchloride (TsCl) (0.55 g, 2.92 mmol) was added directly to the reaction 
vessel. The reaction mixture was allowed to warm up to room temperature, before being 
stirred for an additional 12 h. The solvent was evaporated under reduced pressure, 
washed with H2O, and then finally extracted into CH2Cl2 and dried (Na2SO4). The pure 
ditosylate 3 was obtained by  performing column chromatography [SiO2 : EtOAc] to yield 
the product as a reddish oil (570 mg, 72%). 1H NMR (500 MHz, CDCl3, 298 K): δ = 7.62 
(q, J = 5.1 Hz, 2H), 7.53 (d, J = 8.3 Hz, 4H), 6.60 (q, J = 5.1 Hz, 2H), 4.08-4.03 (m, 4H), 
3.90-3.87 (m, 2H), 3.59−3.53 (m, 4H), 3.49−3.40 (m, 14H), 3.37−3.32 (m, 4H) ppm. 13C 
NMR (125 MHz, CDCl3, 298K): δ = 155.1, 144.9, 140.2, 132.9, 129.8, 127.6, 124.9, 
114.5, 105.6, 70.7, 70.3, 69.2, 68.6, 67.8, 21.6 ppm. MALDI-TOF MS m/z calcd for [M]+ 
820.92; found 820.95.
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Scheme S2.	  The synthesis of the ditosylated BHEEEEN 3
54: The ditosylate 3 (400 mg, 0.49 mmol) and NaN3 (63 mg, 1.00 mmol) were dissolved in 
dry DMF (50 mL). The reaction mixture was heated to 80 ˚C for 12 h under a nitrogen 
atmosphere. The solvent was removed under vacuum and the reaction mixture was 
washed with H2O to remove excess of the azide. The crude compound was extracted into 
CH2Cl2, dried (Na2SO4) and purified by  column chromatography [SiO2:EtOAc] to yield 
the monomeric diazide 3 as a yellow solid (261 mg, 95%). 1H NMR (500 MHz, CDCl3, 
298 K): δ = 7.85 (d, J = 8.47, 2H), 7.33 (t, J = 7.95, 2H), 6.83 (d, J = 7.82, 2H), 4.28 (t, J 
= 4.69, 4H), 3.98 (t, J = 5.06, 4H), 3.80−3.78 (m, 4H), 3.71−3.66 (m, 8H), 3.64−3.61 (m, 
8H), 3.33 (t, J = 5.13, 4H) ppm. 13C NMR (125 MHz, CDCl3, 298K): δ = 153.4, 125.8, 
125.1, 113.4, 104.4, 70.1, 69.8, 69.1, 68.7, 49.6 ppm. MALDI-TOF MS m/z calcd for  [M 
+ Na]+ 585.60; found 585.66. 
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Scheme S3.	  The synthesis of the 1NP diazide 4
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    Scheme S4.	  The synthesis of the 1NP rotaxane [2]1NPR·4PF6
Synthetic Approach to the Preparation of the 1NP-Rotaxane: The diazide 4 (50 mg, 
0.040 mmol) was placed in a round-bottomed flask (100 mL) and dissolved in dry 
Me2CO under a nitrogen atmosphere. CBPQT·4PF6	   (96 mg, 0.088 mmol), tris-
(benzyltriazolylmethyl)amine (TBTA) (21 mg, 0.04 mmol), and the alkyne-functionalized 
stopper precursor 5 (19 mg, 0.088 mmol) were added to this solution and it was stirred 
for 1 h. The solution became deep purple, indicating the formation of the 
pseudorotaxanes. Finally, (Cu(MeCN)4PF6) (21 mg, 0.04 mmol) was added and the 
reaction mixture was stirred for 24 h at room temperature. The solvent was then 
evaporated and the resulting purple solid was purified by RP-HPLC (H2O − MeCN / 0 
100 % in 55 min, λ = 254 nm) to collect [2]1NPR·4PF6 (47 mg, 56%). 1H NMR (600 
MHz, CD3CN, 233K): δ = 1.21 (d, J = 7 Hz, 24H), 2.22 (d, J = 8 Hz, 2H), 3.31 (br t, 4H), 
3.47 (br s, 4H), 3.51 (br s, 4H), 3.70 (br s, 4H), 3.79 (br s, 4H), 3.98 (br s, 4H), 4.11–4.23 
(m, 12H), 4.79 (s, 4H), 5.54 (d, J = 14 Hz, 4H), 5.63 (d, J = 14 Hz, 4H), 5.83 (m, 3H), 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
76.14 (d, J = 8 Hz, 2H), 7.34 (br d, 4H), 7.77 (s, 4H), 7.93 (br s, 2H), 7.94 (br s, 4H), 8.52 
(d, J = 7 Hz, 4H), 8.96 (d, J = 7 Hz, 4H) ppm. 13C NMR (125 MHz, CD3CN, 295K): δ = 
14.4, 23.1, 23.4, 24.3, 27.3, 30.1, 30.3, 32.6, 50.5, 65.9, 68.6, 69.6, 70.4, 71.0, 71.5, 72.0, 
105.1, 109.3, 125.2, 126.0, 137.6, 142.9, 144.7, 146.1, 152.0, 153.7 ppm. ESI-HRMS m/z 
calcd for  [M-3PF6]+ 553.6026; found 553.6029. 
1NP: The diazide 4 (20 mg, 0.013 mmol) was placed in a round-bottomed flask (100mL) 
and dissolved in dry  Me2CO (10 mL) under a nitrogen atmosphere. TBTA (2 mg, 0.007 
mmol) and the alkyne-functionalized stopper precursor 5 (40 mg, 0.014 mmol) were 
added to the solution and it was stirred for 1 h. Finally, (Cu(MeCN)4PF6) (4 mg,  0.007 
mmol) was added, and the reaction mixture was stirred for 24 h at room temperature. The 
solvent was then evaporated and the crude compound was extracted into CH2Cl2, dried 
(Na2SO4), and purified using silica gel column (SiO2: EtOAc) to yield the dumbbell 
compound 1NP as a yellow solid (24 mg, 45%). 1H NMR (600 MHz, CD3CN, 233K) δ = 
7.96 (s, 2H), 7.67 (m, 6H), 7.25 (m, 6H), 7.09 (m, 6H), 6.74 (m, 6H), 4.73 (s, 4H), 4.41 
(t, J = 5 Hz, 4H), 4.08 (br s, 10H), 3.79 (br s, 12H), 3.74 (t, J = 5 Hz, 4H), 3.60 (br s, 
12H), 3.52 (br s, 8H), 3.47 (br m, 8H), 3.43 (br m, 4H), 3.37 (septet, J = 6.5 Hz, 4H), 
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Scheme S5. The synthesis of the dumbbell compound 1NP
81.12 (d, J = 6.5 Hz, 24H) ppm. MALDI-TOF MS m/z calcd for [M]+ 995.25; found: 
995.26.
6: Et3N (880 mg, 1.22 mL, 8.77 mmol) and N, Nʹ′- dimethylaminopyridine (DMAP) (120 
mg, 0.97 mmol) were added to a solution of the diol 2 (5.00 g, 9.75 mmol) in dry CH2Cl2 
(200 mL) at 0 ˚C under a nitrogen atmosphere. After 5 min, a solution of p-toluene- 
sulfonylchloride (TsCl) (1.67 g, 8.77 mmol) in dry CH2Cl2 was added dropwise over a 
period of 1 h. The reaction mixture was allowed to warm up to room temperature, before 
being stirred for an additional 12 h. The solvent was evaporated under reduced pressure, 
washed with H2O, and then finally extracted into CH2Cl2 and dried (Na2SO4). The pure 
monotosylate 6 was obtained by performing column chromatography [SiO2 : EtOAc] to 
yield the product as a reddish oil (2.70 g, 45%). 1H NMR (500 MHz, CDCl3, 298 K): δ = 
7.62 (q, J = 5.1 Hz, 2H), 7.53 (d, J = 8.3 Hz, 4H), 6.60 (q, J = 5.1 Hz, 2H), 4.08-4.03 (m, 
4H), 3.90-3.87 (m, 2H), 3.59−3.53 (m, 4H), 3.49−3.40 (m, 14H), 3.37−3.32 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3, 298K): δ = 161.3, 144.9, 132.9, 129.8, 124.9, 114.5, 105.6, 
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Scheme S6. The synthesis of monotosylated BHEEEEN 6
970.7, 70.3, 69.2, 68.6, 67.8, 61.7, 21.6 ppm. MALDI-TOF MS m/z calcd for [M]+ 666.77; 
found [M]+ 666.08.
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   Scheme S7. The synthesis of the DNP-trimer 7 (3NP)
7: 1,5-Dihydroxynaphthalene (400 mg, 2.52 mmol) was placed in a clean and dry round 
bottom flask, with dry MeCN under a nitrogen atmosphere.  K2CO3 (760 mg, 5.54 mmol) 
and 18-crown-6 (100 mg, 0.25 mmol) were added to this solution and it was heated under 
reflux for 1 h before compound 3 (3.7 g, 5.54 mmol) was added and the reaction mixture 
was refluxed for a further 48 h. The solvent was removed under reduced pressure and the 
reaction mixture washed with H2O and extracted into CH2Cl2. The organic layers were 
dried (Na2SO4) and the solvent was once again evaporated under reduced pressure to 
yield the crude compound. Pure 7 was obtained as a white powder following purification 
of the crude material, first of all by silica gel column chromatography  [SiO2: MeOH / 
EtOAc (15:85)], and then by RP-HPLC [H2O − MeCN / 0  100 % in 55 min, λ = 254 
nm] to obtain 1.2 g (61%) of the pure diol 7. 1H NMR (600 MHz, CDCl3, 298 K): δ = 
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7.87−7.83 (m, 6H), 7.35−7.29 (m, 6H), 6.83−6.77 (m, 6H), 4.30−4.22(m, 12H), 
4.00−3.95 (m, 12H), 3.81−3.77 (m, 12H), 3.73−3.64 (m, 26H), 3.59−3.56 (m, 4H) ppm. 
13C NMR (125 MHz, CDCl3, 298 K): δ = 160.1, 128.7, 123.5, 115.2, 105.6, 70.7, 70.3, 
69.5, 62.8 ppm. MALDI-TOF MS m/z calcd for  [M + Na]+1172.30; found 1172.69 [M + 
Na]+.
8: Et3N (0.51 mL, 3.70 mmol) and DMAP (20 mg, 0.15 mmol) were added to a solution 
of the diol 7 (1.7 g, 1.48 mmol) in dry  CH2Cl2 at 0 ˚C under a nitrogen atmosphere. After 
5 min, solid p-toluenesulfonylchloride (710 mg, 3.70 mmol) was added directly  to the 
reaction vessel. The reaction mixture was allowed to warm up to room temperature, 
before being stirred for 12 h. The solvent was evaporated under reduced pressure, the 
crude mixture washed with H2O, then extracted into CH2Cl2 and dried (Na2SO4). The 
pure ditosylate 8 was obtained by column chromatography [SiO2: EtOAc] yielding a 
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Scheme S8. The synthesis of the ditosylated trimer 8
11
reddish oil (1.62 g, 75%). 1H NMR (600 MHz, CDCl3, 298 K): δ =7.87−7.82 (m, 6H), 
7.77 (d, J = 8.46 Hz, 4H), 7.31 (m, 10H), 6.81−6.77 (m, 6H), 4.28−4.23 (m, 12H), 
4.13-4.11 (m, 4H), 3.98−3.95 (m, 12H), 3.80−3.76 (m, 12H), 3.73-3.70 (m, 8H), 
3.67−3.63 (m, 8H), 3.61−3.54 (m, 8H), 2.40 (s, 6H), ppm. 13C NMR (150 MHz, CDCl3, 
298 K): δ = 23.5, 68.3, 69.9, 70.16, 70.3, 70.4, 105.4, 113.8, 125.1, 128.1, 131.3, 141.7, 
144.1, 144.4, 144.5, 157.9 ppm. MALDI-TOF MS m/z calcd for [M + Na]+ 1480.68; 
found 1480.98 [M + Na]+.
11: The ditosylate 8 (840 mg, 0.56 mmol) and NaN3 (200 mg, 0.17 mmol) were dissolved 
in dry DMF (100 mL). The reaction mixture was heated to 80 ˚C for 12 h under a 
nitrogen atmosphere. The solvent was removed under vacuum and the reaction mixture 
was washed with H2O to remove excess of the azide. The crude compound was extracted 
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Scheme S9. The synthesis of the 3NP trimeric diazide 11
12
into CH2Cl2, dried (Na2SO4) and purified by column chromatography [SiO2:EtOAc] to 
yield the trimeric diazide 11 as a yellow solid (500 mg, 90%). 1H NMR (500 MHz, 
CDCl3, 298 K): δ = 7.78−7.74 (m, 6H), 7.26−7.20 (m, 6H), 6.74-6.67 (m, 6H), 4.21−4.13 
(m, 12H), 3.93−3.85 (m, 12H), 3.73−3.68 (m, 12H), 3.65−3.58 (m, 15H), 3.57−3.53 (m, 
8H), 3.25 (t, J = 5.21, 4H) ppm. 13C NMR (125 MHz, CDCl3, 298K): δ = 154.2, 126.7, 
125.0, 114.5, 105.5, 71.0, 70.8, 69.8, 67.8, 50.6 ppm.
General Synthetic Approach to the Preparation of the 3NP-Rotaxanes: 
The diazide 11 (80 mg, 0.062 mmol) was placed in a round-bottomed flask (100 mL) and 
dissolved in dry Me2CO under a nitrogen atmosphere. CBPQT·4PF6	  (22 mg, 0.20 mmol), 
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Scheme S10. The synthesis of the 3NP rotaxanes [2]3NPR·4PF6, [3]3NPR·8PF6 
and [4]3NPR·12PF6
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tris-(benzyltriazolylmethyl)amine (TBTA) (23 mg, 0.003 mmol), and the alkyne-
functionalized stopper precursor 7 (29 mg, 0.14 mmol) were added to this solution and it 
was stirred for 1 h. The solution became deep purple, indicating the formation of the 
pseudorotaxanes. Finally, (Cu(MeCN)4PF6) (20 mg, 0.003 mmol) was added and the 
reaction mixture was stirred for 24 h at room temperature. The solvent was then 
evaporated and the resulting purple solid was purified by RP-HPLC (H2O − MeCN / 0 
100 % in 55 min, λ = 254 nm). Three different fractions were collected, corresponding 
to [2]3NPR·4PF6 (20 mg, 10%), [3]3NPR·8PF6 (55 mg, 45%) and [4]3NPR·12PF6 (15 
mg, 3%). 
[2]3NPR·4PF6: 1H NMR (600 MHz, CD3CN, 233 K): δ = 8.74 (d, J = 6.8 Hz, 4H), 8.13 
(d, J = 6.6 Hz, 4H), 8.02 (s, 2H), 7.85−7.83 (b, 4H), 7.75-7.73 (b, 4H), 7.20 (b, 1H), 7.19 
(b, 1H), 7.17 (d, J = 2.05 Hz, 2H), 7.16 (b, 2H), 7.14−7.16 (b, 3H), 7.05−6.98 (m, 6H), 
6.57−6.54 (b, 4H), 6.52 (d, J = 7.3 Hz, 2H), 6.47−6.44 (b, 4H), 6.33 (d, J = 7.7 Hz, 2H), 
5.84 (d, J = 8.5 Hz, 2H), 5.71 (d, J = 13.7 Hz, 4H), 5.58 (d, J = 8.5 Hz, 2H), 5.53 (d, J = 
14.7 Hz, 4H), 4.80 (s, 4H), 4.52 (t, J = 4.7 Hz, 4H), 4.04−3.94 (b, 18H), 3.90−3.86 (b, 
4H), 3.83−3.78 (b, 14H), 3.69−3.62 (b, 12H), 3.59−3.54 (b, 8H), 3.54−3.50 (b, 5H), 
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3.50−3.46 (b, 5H), 3.46−3.42 (b, 5H), 3.41 (m, 4H), 1.17 (d, J = 7.0 Hz, 24H) ppm. 13C 
NMR (150 MHz, CD3CN, 233K): δ = 154.2, 153.3, 141.7, 129.6, 126.2, 125.4, 124.3, 
117.5, 114.0, 105.3, 72.6, 70.6, 70.4, 70.3, 70.1, 69.4, 67.6, 60.8, 26.2, 23.8 ppm. ESI-
HRMS m/z calcd for [M – PF6]+ 2587.0296; found: 2587.0289; calcd for [M − 2PF6]2+ 
1221.5343; found: 1221.5356; calcd for [M − 3PF6]3+ 765.7004; found: 765.7013.
[3]3NPR·8PF6:1H NMR (600 MHz, CD3CN, 233 K): δ = 8.89 (d, J = 7.6 Hz, 4H), 8.78 
(d, J = 7.5 Hz, 4H), 8.41 (d, J = 7.5 Hz, 4H), 8.13 (d, J = 7.5 Hz, 4H) 7.89 (s, 2H), 7.88 
(b, 8H), 7.73 (d, J = 11.5, 8H), 7.19 (m, 2H), 7.18 (s, 2H), 7.16−7.13 (m, 2H), 7.03−7.00 
(b, 4H), 7.00−6.95 (b, 8H), 6.92−6.84 (m, 4H), 6.84−6.80 (b, 4H), 6.25 (d, J = 7.5 Hz, 
2H), 6.05 (d, J = 8.0, 2H), 6.00 (d, J = 7.5 Hz, 2H), 5.76 (d, J = 8.6 Hz, 2H), 5.70 (d, J = 
8.6 Hz, 2H), 5.65 (d, J = 13.8 Hz, 4H), 5.57−5.52 (m, 8H), 5.46 (d, J = 14.4 Hz, 4H), 
4.76 (s, 4H), 4.19 (t, J = 5.2 Hz, 18H), 4.15−4.05 (b, 16H), 3.99−3.96 (b, 4H), 3.95−3.91 
(b, 4H), 3.89−3.85 (b, 4H), 3.80−3.75 (b, 8H), 3.68−3.61 (b, 12H), 3.57−3.52 (b, 4H), 
3.51−3.48 (b, 4H), 3.45−3.38 (m, 8H), 1.18 (d, J = 7.0 Hz, 26H) ppm. 13C NMR (150 
MHz, CD3CN, 233K): δ = 153.0, 152.3, 150.6, 144.2, 144.0, 143.3, 141.5, 136.1, 130.8, 
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127.6, 125.4, 124.8, 123.8, 117.0, 113.4, 107.7, 105.5, 103.7, 70.6, 70.2, 70.0, 69.6, 69.2, 
69.1, 68.8, 68.3, 67.8, 67.4, 64.5, 49.2, 29.5, 25.9, 23.0 ppm. ESI-HRMS m/z calcd for 
[M − 2PF6]2+ 1771.5939; found: 1771.5950; calcd for [M − 3PF6]3+ 1132.4068; found: 
1132.4081; calcd for [M − 4PF6]4+ 813.0641; found: 813.0647; calcd for [M − 5PF6]5+ 
621.4584; found: 621.4595.  
[4]3NPR·12PF6: 1H NMR (600 MHz, CD3CN, 233 K): δ = 8.97 (d, J = 7.1 Hz, 4H), 
8.94−8.91 (b, 8H), 8.64 (t, J = 7.4 Hz, 8H), 8.53 (d, J = 7.1 Hz, 4H) 7.96−7.92 (m, 14H), 
7.91−7.89 (b, 8H), 7.79−7.77 (b, 8H), 7.42−7.38 (m, 8H), 7.34−7.32 (m, 4H), 7.22−7.19 
(b, 4H), 7.18−7.12 (b, 14H), 6.22−6.14 (m, 6H), 5.95−5.88 (m, 4H), 5.88−5.84 (m, 2H), 
5.73−5.60  (m, 22H), 5.58−5.52 (d, J = 13.7, 4H), 4.78 (s, 4H), 4.26−4.12 (b, 28H), 
4.06−3.96 (b, 22H), 3.81−3.77 (b, 4H), 3.71−3.68 (b, 4H), 3.53−3.49 (b, 4H), 3.49−3.42 
(m, 4H), 3.37−3.32 (b, 4H), 2.28−2.22 (b, 6H), 1.20 (d, J = 7.0 Hz, 24 H) ppm. 13C NMR 
(150 MHz, CD3CN, 233K): δ = 156.9, 140.5, 132.1, 130.0, 125.0, 120.9, 118.1, 79.2, 
43.7, 30.7, 28.4, 26.8, 24.4 ppm. ESI-HRMS m/z calcd for [M − 2PF6]2+ 2321.6558; 
found: 2321.6443; calcd for [M − 3PF6]3+ 1499.4492; found: 1499.4440; calcd for [M − 
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4PF6]4+ 1088.3459; found: 1088.3445; calcd for [M − 5PF6]5+ 841.6839; found: 
841.6828; calcd for [M − 6PF6]6+ 677.2426; found: 677.2426.
3NP: The diazide 11 (20 mg, 0.013 mmol) was placed in a round-bottomed flask 
(100mL) and dissolved in dry Me2CO (10 mL) under a nitrogen atmosphere. TBTA (2 
mg, 0.007 mmol) and the alkyne-functionalized stopper precursor 5 (40 mg, 0.014 mmol) 
were added to the solution and it was stirred for 1 h. Finally, (Cu(MeCN)4PF6) (4 mg, 
0.007 mmol) was added, and the reaction mixture was stirred for 24 h at room 
temperature. The solvent was then evaporated and the crude compound was extracted into 
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Scheme S11. The synthesis of the dumbbell compound 3NP
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CH2Cl2, dried (Na2SO4), and purified using silica gel column (SiO2: EtOAc) to yield the 
dumbbell compound 3NP as a yellow solid (24 mg, 62%). 1H NMR (600 MHz, CD3CN, 
233K) δ = 7.96 (s, 2H), 7.67 (m, 6H), 7.25 (m, 6H), 7.09 (m, 6H), 6.74 (m, 6H), 4.73 (s, 
4H), 4.41 (t, J = 5 Hz, 4H), 4.08 (br s, 10H), 3.79 (br s, 12H), 3.74 (t, J = 5 Hz, 4H), 3.60 
(br s, 12H), 3.52 (br s, 8H), 3.47 (br m, 8H), 3.43 (br m, 4H), 3.37 (septet, J = 6.5 Hz, 
4H), 1.12 (d, J = 6.5 Hz, 24H) ppm. MALDI-TOF MS m/z calcd for [M]+ 1631.98; found: 
1631.96.
9: 1,5-Dihydroxynaphthalene (10 g, 62.4 mmol) was added to a dry round-bottomed flask 
and dry MeCN was added under nitrogen. K2CO3 (7.76 g, 56.19 mmol) and 18-crown-6 
(120 mg, 6.24 mmol) were added to the reaction mixture and it  was heated under reflux 
for 30 min. A solution of 1 (19.6 g, 56.19 mmol) in MeCN was added dropwise to the 
reaction vessel over a period of 1 h and the reaction was continued for an additional 12 h. 
The solvent was removed under vacuum, the crude material was washed with H2O and 
organic layer was extracted in CH2Cl2. The crude product was purified by column 
chromatography  [SiO2: MeOH: EtOAc (5:95)] to yield a greenish yellow oil 9 (7.1 g, 
54%). 1H NMR (500 MHz, CD3CN, 298 K): δ = 7.91 (d, J = 8.4 Hz, 2H), 7.48 (t, J = 7.8 
Hz, 1H), 7.39 (t, J = 7.8, 1H), 6.88 (d, J = 7.7 Hz, 2H), 4.39 (t, J = 4.7, 2H), 3.98 (t, J = 
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Scheme S12. The synthesis of the monofunctionalized DNP 9
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4.9 Hz, 2H), 3.76−3.74 (m, 2H), 3.70−3.63 (m, 8H), 3.49−3.51 (m, 2H) ppm. 13C NMR 
(125 MHz, CDCl3 298K): δ = 154.5, 153.9, 128.6, 126.7, 125.1, 114.5, 105.6, 70.6, 69.9, 
67.8, 61.6 ppm. MALDI-TOF MS m/z calcd for [M]+ 336.37; found 336.41.
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Scheme S13. The synthesis of the DNP-pentamer 10 (5NP)
        
10: K2CO3 (60 mg, 0.43 mmol) and 18-crown-6 (10 mg, 0.02 mmol) were added to a 
solution of 9 (150 mg, 0.43 mmol) in dry MeCN, and the reaction mixture was heated 
under reflux for 30 min. A solution of 8 (250 mg, 0.17 mmol) in dry MeCN (100 mL) 
was added and the mixture was refluxed for an additional 36 h under a nitrogen 
atmosphere. The solvent was removed under reduced pressure, the crude mixture washed 
with H2O and the organic layer extracted in CH2Cl2. Finally, it  was dried (Na2SO4) and 
the crude product was purified by column chromatography [SiO2: MeOH: EtOAc 
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(15:85)] to yield the diol 10 as a yellow solid (170 mg, 67 %). 1H NMR (500 MHz, 
CDCl3, 298 K): δ = 7.84 (m, 10H), 7.31 (m, 10H), 6.79 (m, 10H), 4.30−4.22 (b, 20H), 
4.00−3.94 (b, 20H), 3.82−3.76 (b, 21H), 3.74−3.64 (b, 36H), 3.58 (m, 6H) ppm. 13C 
NMR (125 MHz, CDCl3, 298K): δ = 154.3, 126.8, 125.0, 114.5, 105.6, 71.1, 69.6, 68.0, 
61.7 ppm. MALDI-TOF MS m/z calcd for [M + Na]+1809.03; found 1809.04.
12: Compound 10 (170  mg, 0.096 mmol) was dissolved in dry CH2Cl2 and mixed with 
Et3N (110 mg, 0.15 mL, 0.57 mmol) and DMAP (20 g, 0.01 mmol). The reaction mixture 
was stirred for 15 min at 0 ˚C under a nitrogen atmosphere. TsCl (110 mg, 0.57 mmol) 
was added to this solution and the reaction mixture was kept at room temperature for 24 
h. After completion of the reaction, the solvent was removed under reduced pressure and 
the crude product washed with H2O and extracted into CH2Cl2. After drying the crude 
product (Na2SO4) purification by  column chromatography (SiO2: EtOAc) yielded the 
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20
ditosylate 12 as a yellow oil (160 mg, 83%). 1H NMR (500 MHz, CDCl3, 298 K): δ = 
7.84 (m, 10H), 7.71 (d, J = 8.3 Hz, 4H), 7.34−7.28 (m, 14H), 6.82−6.78 (m, 10H), 
4.28−4.22 (b, 20H), 4.14−4.10 (m, 10H), 3.89−3.94 (m, 20H), 3.80−3.75 (b, 19H), 
3.73−3.69 (b, 15H), 3.567−3.63 (b, 10H), 3.60−3.54 (b, 10H), 2.41 (s, 6H) ppm. 13C 
NMR (125 MHz, CDCl3, 298K): δ = 154.7, 130.6, 128.7, 126.8, 125.5, 114.6, 105.8, 
70.8, 69.8, 68.7, 21.5 ppm. MALDI-TOF MS m/z calcd for [M  + Na]+ 2117.40; found 
2117.10.
                   
12
O
O
O O O
OO
O O O
O
O
OO
O O
O
O O
TsOO
O O O
O
O O O
OTs
O
13
O
O
O O O
OO
O O O
O
O
OO
O O
O
O O
N3O
O O O
O
O O O
N3
O
NaN3 / DMF / 80 ˚C 
          12 h
89%
       Scheme S15. The synthesis of the 5NP pentameric diazide 13
13: The ditosylate 12 (160 mg, 0.08 mmol) was dissolved in dry DMF (100 mL) along 
with NaN3 (40 mg, 0.64 mmol). The reaction mixture was heated to 80 ˚C during 12 h 
under a nitrogen atmosphere. The solvent was removed under vacuum and reaction 
mixture was washed with H2O to remove excess of the sodium azide. The crude product 
was extracted into CH2Cl2, dried (Na2SO4) and purified by column chromatography 
(SiO2: EtOAc) to yield the bisazide 13 as a yellow solid (140 mg, 89%). 1H NMR (500 
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MHz, CDCl3, 298 K): δ = 7.86−7.82 (m, 10H), 7.34−7.28 (m, 12H), 6.82−6.76 (m, 10H), 
4.29−4.22 (m, 22H), 4.00−43.94 (m, 22H), 3.81−3.76 (m, 20H), 3.73−3.65 (b, 36H), 3.34 
(t, J = 5.1, 4H) ppm. 13C NMR (125 MHz, CDCl3, 298K): δ = 156.9, 140.5, 132.1, 130.0, 
125.0, 120.9, 118.1, 79.2, 51.2 ppm. MALDI-TOF MS m/z calcd for [M + Na]+ 1859.06; 
found 1859.07.
General Synthetic Approach to the Preparation of the 5NP-Rotaxanes: The diazide 
13 (250 mg, 0.014 mmol) was placed in a round-bottomed flask (100 mL) and dissolved 
in dry  Me2CO (50 mL) under a nitrogen atmosphere. CBPQT·4PF6	  (39 mg, 0.035 mmol), 
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Scheme S16. The synthesis of the 5NP rotaxanes [3]5NPR·8PF6 and 
[4]5NPR·12PF6
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TBTA (2 mg, 0.007 mmol), and the alkyne-functionalized stopper precursor 7 (76 mg, 
0.035 mmol) were added to the Me2CO solution and the reaction mixture stirred for 1 h. 
It became deep  purple, indicating the formation of the pseudorotaxanes. Finally, (Cu
(MeCN)4PF6) (3 mg,  0.007 mmol) was added and the reaction mixture was stirred for 24 
h at room temperature. The solvent was then evaporated and the resulting purple solid 
was purified by RP-HPLC (H2O − MeCN / 0  100 % in 55 min, λ = 254 nm). Two 
fractions were collected, namely the [3]rotaxane [3]5NPR·8PF6 (15 mg, 50 %), and the 
[4]rotaxane [4]5NPR·12PF6 (20 mg, 20 %).         
      
[3]5NPR·8PF6: 1H NMR (600 MHz, CD3CN, 233 K): δ = 8.94 (d, J = 7.1 Hz, 1H), 
8.76−8.65 (b, 6H), 8.42 (d, J = 7.1 Hz, 1H), 8.23 (d, J = 7.2 Hz, 1H), 8.13−8.08 (b, 4H), 
8.06 (d, J = 7.2 Hz, 1H), 8.01 (d, J = 5.9 Hz, 1H), 7.94−7.89 (b, 2H), 7.85−7.79 (b, 6H), 
7.79−7.76 (b, 1H), 7.74−7.69 (b, 5H), 7.67−7.65 (b, 1H), 7.25−7.19 (m, 2H), 7.19−7.10 
(b, 8H), 7.08−6.99 (b, 6H), 6.99−6.94 (b, 2H), 6.91−6.88 (b, 1H), 6.82−6.74 (b, 2H), 
6.72−6.69 (b, 1H), 6.66−6.46 (b, 10H), 6.46−6.43 (b, 1H), 6.38 (d, J = 8.2 Hz, 1H), 6.34 
(d, J = 8.2 Hz, 1H), 6.31 (t, J = 8.2 Hz, 1H), 6.15 (d, J = 7.9 Hz, 1H), 6.04 (d, J = 7.9 Hz, 
1H), 5.98 (d, J = 7.9 Hz, 1H), 5.87−5.81 (b, 2H), 5.72−5.41 (b, 18H), 4.78 (d, J = 5.8 Hz, 
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2H), 4.73 (s, 2H), 4.54−4.49 (m, 2H), 4.19−3.74 (b, 54H), 3.69−3.37 (b, 41H), 3.38−3.34 
(m, 2H), 1.20−1.12 (m, 24H). 13C NMR (150 MHz, CD3CN, 233K): δ = 153.5, 150.9, 
148.1, 145.9, 144.8, 144.3, 143.8, 139.6, 137, 131.9, 131.3, 130.7, 130.4, 128.9, 128.1, 
125.6, 124.5, 113.6, 70.0, 69.6, 67.6, 64.7, 63.1, 34.1, 33.4, 30.8, 23.6, 13.7 ppm. ESI-
HRMS m/z calcd for [M − 2PF6]2+ 2088.7371; found: 2088.7172; calcd for [M − 3PF6]3+ 
1344.1698; found: 1344.1646; calcd for [M − 4PF6]4+ 971.8862; found: 971.8871.
	  	  	  	  	  	  
O
O O O
O
N
OO
O O O
N NN
O
O O O
N N
O
OO
O O O O O
O
N N
N N
N N
OO
O OO
N
N
N
O
N
NN O
12PF6
[4]5NPR.12PF6
[4]5NPR·12PF6: 1H NMR (600 MHz, CD3CN, 233 K): δ = 8.86 (d, J = 6.2 Hz, 4H), 8.74 
(d, J = 6.2, 4H), 8.66 (d, J = 6.2 Hz, 4H), 8.38 (d, J = 6.2 Hz, 4H), 8.25 (d, J = 6.4 Hz, 
4H), 8.08 (d, J = 6.2 Hz, 4H), 7.90 (s, 2H), 7.84 (s, 8H), 7.78 (s, 4H), 7.71 (s, 4H), 7.66 
(d, J = 12.9, 8H), 7.20−7.13 (m, 7H), 6.96 (d, J = 5.6 Hz, 4H), 6.93 (t, J = 7.8, 8H), 
6.83−6.75 (b, 8H), 6.73 (d, J = 8.4 Hz, 2H) 6.69 (d, J = 8.4 Hz, 2H), 6.53 (d, J = 5.6 Hz, 
4H), 6.49 (d, J = 5.6 Hz, 4H), 6.16 (d, J = 7.3 Hz, 4H), 6.01 (d, J = 7.3 Hz, 2H), 5.96 (d, 
J = 7.3 Hz, 2H), 5.83 (d, J = 7.3 Hz, 2H), 5.73 (t, J = 7.3, 2H), 5.62−5.58 (m, 8H), 
5.56−5.47 (m, 14H) 5.46−5.39 (b, 8H), 4.75 (s, 4H), 4.18−4.13 (b, 6H), 4.11−4.02 (b, 
18H), 4.01−3.89 (b, 22H), 3.88−3.81 (b, 9H), 3.69−3.61 (b, 18H), 3.51−3.46 (b, 8H), 
3.46−3.39 (b, 9H), 3.37−3.33 (b, 4H), 2.01 (d, J = 7.8 Hz, 2H), 1.86 (d, J = 7.8 Hz, 2H), 
1.18 (d, J = 6.8 Hz, 24H). 13C NMR (150 MHz, CD3CN, 233K): δ = 156.1, 152.2, 148.1, 
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145.9, 144.8, 144.3, 143.8, 138.4, 131.9, 131.3, 130.7, 130.4, 128.9, 128.1, 125.6, 124.5, 
113.6, 70.0, 69.6, 67.6, 64.7, 63.1, 35.3, 32.4, 29.2, 24.5 ppm. ESI-HRMS m/z calcd for 
[M − 3PF6]3+ 1710.8763; found: 1710.8693; calcd for [M − 4PF6]4+ 1246.9161; found: 
1246.8966.
5NP: The diazide 13 (25 mg, 0.013 mmol) was placed in a round-bottomed flask (100 
mL) and dissolved in dry Me2CO (10 mL) under a nitrogen atmosphere. TBTA (2 mg, 
0.007 mmol), and the alkyne-functionalized stopper precursor 7 (40 mg, 0.014 mmol) 
were added to the solution and it was stirred for 1 h. Finally, (Cu(MeCN)4PF6) (4 mg, 
0.007 mmol) was added and the reaction mixture was stirred for 24 h at room 
temperature. The solvent was then evaporated and the crude compound was extracted into 
CH2Cl2, dried (Na2SO4) and purified by  column chromatography  (SiO2: EtOAc) to yield 
the dumbbell compound 5NP as a yellow solid (20 mg, 56%). 1H NMR (600 MHz, 
CD3CN, 233K) δ = 7.96 (s, 2H), 7.68 (br d, 6H), 7.61 (br s, 3H), 7.27 (m, 10H), 7.10 (m, 
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Scheme S17. The synthesis of the dumbbell compound 5NP
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6H), 6.74 (m, 10H), 4.74 (s, 4H), 4.42 (t, J = 4 Hz, 4H), 4.10 (br m, 24H), 3.81 (br s, 
20H), 3.76 (t, J = 4 Hz, 4H), 3.62 (br s, 20H), 3.55 (br s, 18H), 3.49 (m, 8H), 3.45 (m, 
4H), 3.37 (septet, J = 7 Hz, 4H), 1.13 (d, J = 7 Hz, 24H) ppm. MALDI-TOF MS m/z 
calcd for [M]+ 2269.71; found: 2269.72. 
3. Analysis of the 1H NMR Spectra of the Rotaxanes
The rotaxanes [2]3NPR.4PF6, [3]3NPR.8PF6, [4]3NPR.12PF6 based on the dumbbell 
3NP and the rotaxane [4]5NPR.12PF6 utilizing the dumbbell 5NP were characterized 
fully  by 1H NMR spectroscopy. Assignments of resonances to protons were confirmed by 
1H–1H gDQF-COSY and 1H–1H gNOESY, recorded on a Bruker Avance 600 MHz 
spectrometer at 233K in CD3COCD3 or CD3CN. A complete assignment in the slow 
exchange regime for the [3]5NPR.8PF6 was not possible because of considerable line 
broadening associated with multiple dynamic processes occurring within the molecule on 
the 1H NMR timescale. Based on previous investigations carried out on CBPQT4+-
containing compounds, the following protons were chosen as probes in order to 
determine the preferred (co-)conformations of the rotaxanes in solution: the α and β 
protons on the bipyridinium units on the CBPQT4+ rings and the H2/6 protons on the π-
electron rich DNP units. In the absence of the guest (DNP units), the α and β protons 
associated with the BIPY2+ units resonate as a couple of doublets (δ = 8.89 and 8.16 ppm) 
in CD3CN at 233 K. When a CBPQT4+ ring encircles a DNP unit, the α and β protons 
appear as four doublets on account of the local C2 symmetry imposed on the BIPY2+ unit 
by the DNP ring system.
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3A. 1H NMR Spectra of the Rotaxanes Recorded in CD3CN at 233K
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S2. 1H NMR Spectrum (600 MHz) of [3]3NPR·8PF6	  recorded in CD3CN at 233 K
Figure S1. 1H NMR Spectrum (600 MHz) of [2]3NPR·4PF6	  recorded in CD3CN at 233 K
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Figure S4. 1H NMR Spectrum (600 MHz) of [4]5NPR·12PF6	  recorded in CD3CN at 233 K
Figure S3. 1H NMR Spectrum (600 MHz) of [4]3NPR·12PF6	  recorded in CD3CN at 233 K
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3B. Correlation Spectroscopy Performed on the Rotaxanes in CD3CN at 233K
The 1H-1H gDQF-COSY of [2]3NPR·4PF6 (Figure S5) in CD3CN at 233K reveals 
correlation peaks between α and β protons of the CBPQT4+ ring. The peaks for the 
protons i3/7 and i4/8 of the DNP unit which reside inside the π-electron deficient 
tetracationic cyclophane are visible as indicated by  i3/7 ↔ i4/8 in the spectrum. As 
expected, the i4/8 is shifted upfield to the 2 ppm region because of an edge-to-face CH-π 
interaction with the bridging phenylene moieties in the CBPQT4+ ring. The DNP protons 
o3/7, which are not included in the cavity of the tetracationic cyclophane are also present, 
showing clear correlations with o2/6 and o4/8.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S5. 1H − 1H gDQF-COSY Spectrum (600 MHz) of the [2]3NPR·4PF6	  
recorded in CD3CN at 233 K
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The 1H-1H gDQF-COSY (Figure S6) of [3]3NPR·8PF6  in CD3CN at 233 K reveals 
strong correlation peaks between the α and β protons of the CBPQT4+ ring. Unlike 
[2]3NPR·4PF6 (Figure S5), all the α and β protons are heterotopic (as denoted by oα, aα 
and oβ, aβ peaks respectively) COMEBACK. The correlation spectrum clearly 
demonstrates four different sets of both α and β resonances. The peaks for the protons 
i2/6, i3/7 and i4/8 of the DNP units that reside inside the π-electron deficient tetracationic 
cyclophane are labeled in the spectrum. The DNP protons that are not included in the 
cavity of CBPQT4+ but have strong alongside interactions with the BIPY2+ units of the 
macrocycle (a3/7, a2/6 and a4/8) are also present and labeled in the spectrum.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S6. 1H − 1H gDQF-COSY Spectrum (600 MHz) of [3]3NPR·8PF6 recorded in 
CD3CN at 233 K
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The 1H-1H gDQF-COSY of [4]3NPR·12PF6 (Figure S7) in CD3CN at  233 K showed six 
sets of α and β protons arising from the CBPQT4+ ring – all of which are denoted as ‘o’, 
since none of them have an alongside interaction with the DNP units. The known 
association of the oα  protons (a-f) allowed for easy assignment of the corresponding oβ 
signals as labeled in Figure S7. Unlike [2]3NPR·4PF6 (Figure S5) and [3]3NPR·8PF6 
(Figure S6) all DNP subunits are included in the cavity  of the CBPQT4+ ring, as denoted 
by the letter ‘i’. The chemical shifts of the protons i2/6, i3/7 and i4/8 (of the central NP unit) 
are different  from the DNP recognition units denoted by i2-i6 present on the outer DNP 
unit.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S7. 1H − 1H gDQF-COSY Spectrum (600 MHz) of [4]3NPR·12PF6 recorded in 
CD3CN at 233 K
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The 1H-1H gDQF-COSY (Figure S8) of [4]5NPR·12PF6 in CD3CN at 233 K reveals six 
separate doublets for the α and β protons associated with the three CBPQT4+ rings, two of 
which are denoted as ‘o’. These signals correspond to the BIPY2+ units which face the 
stoppers (outside) of the rotaxane. The remaining BIPY2+ resonances are referred to as 
‘a’ since they demonstrate alongside interactions with the DNP subunits (Table 1 in the 
main text). The protons from the DNP subunits are very similar to the [3]3NPR·8PF6 in 
having two sets of signals – included protons (i1-i6) which are located inside the cavity  of 
the CBPQT4+ ring and the alongside protons (a1-a6) that has side on interactions with the 
BIPY2+ subunits. The peaks for the protons i2/6, i3/7 and i4/8 (of the central DNP unit) are 
different from the DNP recognition units denoted by i2-i6 present on the outer DNP unit, 
as seen in [4]3NPR·8PF6. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S8. 1H − 1H gDQF-COSY Spectrum (600 MHz) of [4]5NPR·12PF6 recorded 
in CD3CN at 233 K
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3C. Nuclear Overhauser Effect Spectroscopy (NOESY)
The 1H-1H gradient-selected NOESY (Figure S9) of [2]3NPR·4PF6  in CD3COCD3 at 233 
K was utilized to further elucidate the solution state structure of these molecule. We focus 
on the nOe signals between the proton labeled O6 on the terminal DNP unit  and the aβa 
protons from the CBPQT4+ ring. This correlation presents strong evidence for the folded 
conformation of these donor-acceptor systems in the solution state.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S9. 1H − 1H gNOESY spectrum (600 MHz) of [2]3NPR·4PF6 recorded in 
CD3COCD3 at 233 K
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The 1H−1H gradient-selected NOESY (Figure S10) of [3]3NPR·8PF6  in CD3COCD3 at 
233K provides further evidence for a folded conformation, similar to that for 
[2]3NPR·4PF6. We focused on the nOe correlation between the O6 of the terminal DNP 
unit and aβa protons arising from the CBPQT4+ ring. This correlation presents strong 
evidence for the folded conformation of the molecule in the solution state.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S10. 1H − 1H gNOESY Spectrum (600 MHz) of [3]3NPR·8PF6  recorded in 
CD3COCD3 at 233 K
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X-Ray Crystallography
Slow vapor diffusion of iPr2O into a MeCN solution of 3NP⊂(CBPQT·4PF6)2 at 298 K 
afforded deep purple single crystals suitable for X-ray crystallographic analysis (Figure 
S12). 3NP⊂(CBPQT·4PF6)2 is stabilized by intermolecular noncovalent [π···π], [C–H···π] 
and [C–H···O] interactions (Figure S11b). The face-to-face [π···π] interplanar separations 
(Figure S11a) between the inside DNP unit and the center of the outside                              
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
S11. A ball-and-stick representation of the X-ray crystal superstructure of 3NP⊂
(CBPQT·4PF6)2 illustrating (a) the face-to-face [π···π] and the edge-to-face [C−H···π] 
noncovalent bonding distances between the CBPQT4+ rings (blue) and the DNP units 
(red) and (b) the [C−H···O] distances between the oxygen atoms of the tetraethylene 
glycol thread and the CBPQT4+ rings.
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BIPY2+ unit and the inside one is 3.30 Å and 3.28 Å respectively. The distance between 
the middle DNP unit and the inside BIPY2+ unit is 3.36 Å. The edge-to-face [C–H···π] 
interactions between the inside DNP units and the p-xylylene of the CBPQT4+ ring (3.41 
Å and 3.44 Å, see Figure S11a) further stabilize the folded superstructure in the solid 
state. Upon closer examination of the solid-state crystal superstructure of the [3]
pseudorotaxane 3NP⊂(CBPQT·4PF6)2, it can be observed (Figure S11b) that 8 [C–H···O] 
interactions exist between the CBPQT4+ rings and 3NP adding further stability  to the 
folded conformation of the pseudorotaxane. The solid-state packing (Figure S12) of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure S12. A space-filling representation of the packing of the [3]pseudorotaxane 
3NP⊂(CBPQT·4PF6)2 in the solid-state, illustrating noncovalent face-to-face [π···π] 
interactions between the p-xylylene of the CBPQT4+ rings.
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3NP⊂(CBPQT·4PF6)2 is mediated by noncovalent face-to-face [π···π] interactions 
between the p-xylylenes of the CBPQT4+ rings. 
X-Ray Crystal Data. The X-ray crystal data for compound 3NP⊂(CBPQT·4PF6)2	  was 
collected at 173 K using a Rigaku 007HF RA generator (Cu-Kα radiation) equipped with 
confocal optics and Saturn 944+ CCD system.  Intensities were corrected for Lorentz-
polarization and for absorption. The superstructure was solved by direct methods. 
Hydrogen atoms bound to carbon were idealized. Structural refinements were obtained 
with full-matrix least-squares based on F2 by using the program SHELXTL. CCDC 
769519 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html or from the 
Cambridge Crystallographic Data centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax 
(+44) 1223-336-033; e-mail: deposit@ccdc.cam.ac.uk.
Crystal data for 3NP⊂(CBPQT·4PF6)2: 2(C62H84O20)4(C36H32N4)16(F6P)24(C2H3N)O, M 
= 2142.80, space group C 2/c, monoclinic, a =  23.1974(12), b = 14.9199(8), c = 51.042
(3) Å,  α = 90.00 o, β = 100.175(2)˚,γ = 90.00o, U = 17387.9 Å3, Z = 2, Z' = 0, µ = 2.427 
mm-1, 126248 reflections collected, 11023 observed independent reflections (Rint  0.0854) 
gave R  0.1969 for I > 2σ(I) and wR(F2) was 0.5261.
Computational Methods: Calculations were performed on all systems using density 
functional theory (DFT) with the M06-L and M06-2X functionals, as implemented in 
Jaguar 7.6.  Starting with a structure from the crystallographic data we optimized the 
geometry using the 6-31G** basis set with the M06-L functional in the gas phase. Single 
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point energies were calculated using the M06-2X functional and the 6-311++G** basis 
set.  Solvent corrections were based on single point self-consistent Poisson-Boltzmann 
continuum solvation calculations for acetonitrile (å = 37.5, R0= 2.18 Å) using the PBF 
module in Jaguar.
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